®
A global solution for supplier pre-assessments in the sourcing of animal studies
How VERIF.i supports suppliers of animal studies
Pre-assessments designed to ensure compliance in animal welfare
Improve Reputation
Demonstrate to clients your commitment to ethical and responsible animal treatment to differentiate from competition
Increase Visibility
Showcase your capabilities and advantages to researchers and potential clients to increase new business opportunities
Improve Efficiency
Review and optimize your animal welfare processes to boost cost savings and improve management
Align with Industry
Understand the specific requirements and expectations of clients, and better meet those needs
Enhance Quality
Ensure practices comply with regulations while enhancing the quality of animal welfare practices
Want to learn more about how Scientist.com's VERIF.i program helps global suppliers of animal studies?
Standardized physical lab inspections
Facility, personnel and processes evaluation
VERIF.i® is an on-site pre-assessments program designed to save researchers and suppliers time, money and resources by allowing prospective and existing customers to proactively evaluate a supplier's organization to reduce risk and enable them to demonstrate capabilities that differentiate their organization within the market. Scientist.com has developed VERIF.i to cover research in the categories of animal welfare, human biosamples (HBS) and chemistry, manufacturing and controls (CMC).
For suppliers, VERIF.i pre-assessments demonstrate organizational quality and capabilities, enabling market differentiation based on factors potential clients care about most.
For researchers, VERIF.i pre-assessments aid in supplier selection in an accelerated manner with more confidence and less risk.
Are you a researcher curious for more information on how Scientist.com's VERIF.i program can benefit your organization? Download our report, "How VERIF.i Offers Biopharma Researchers a Solution for On-site Supplier Pre-Assessments Both During and After the Pandemic."